KNSA
KINIKSA PHARMACE
Health Care·Biotechnology·BRITAIN
$77.91
MCap $6.1B
as of 2026-09-04
Total
B10w
Fund
C10w
Quant
A10w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
-0.97
Sentiment 89.3%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$77.91
Adaptive Mean
$79.41
-1.50 vs mean
Adaptive σ
0.78
MIDOS BB
$77.86 – $80.97
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
+0.12
ROE
14.0%
Z +0.48
Rev Gr
55.4%
Z +0.17
EPS Gr
30.4%
Z -0.44
OPM Gr
-1.7%
Z -0.07
FCF Yld
2.1%
Z +0.28
EPS Surp
0.1%
Z +0.25
EPS 3mo Δ
37.0%
Z +0.13
Fwd P/E
48.17
Z —
PEGY
1.58
Fair
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
19.68
Q6M
11.39
Q12M
10.14
MA 30/100
1.256
Bullish (MA30 > MA100)
α (Jensen)
2.0487
β (12M)
0.26
σ (12M)
0.497
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
71%
Q Percentile
97%
Divergence
-26.3
Tier
TRIM — WATCH
Momentum ahead of fundamentals.
Kirkpatrick RS & Persistence
RS
58.5
RS Pctl
94%
RS Decile
D10
Persistence
10w
at grade B
Options / OI Analysis
as of 2026-09-04
OI Center
$80.69
+3.6% from spot
Max Pain
$75.00
PCR (OI)
0.03
contrarian_bearish
Skew
0.69
OI Composite
-1
neutral
Direction
bullish